Shakti Press Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Nov 01, 2026

Key Highlights

The Latest Trading Price of Shakti Press Ltd is ₹ 9.91 as of 28 Sep 12:28 . The P/E Ratio of Shakti Press Ltd changed from 25.1 on March 2024 to 5.1 on March 2026 . This represents a CAGR of -41.21% over 3 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Shakti Press Ltd changed from ₹ 12 crore on March 2024 to ₹ 8.36 crore on March 2026 . This represents a CAGR of -11.35% over 3 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Shakti Press Ltd for the Jun '26 is ₹ 27.66 crore as compare to the Mar '26 revenue of ₹ 65.84 crore. This represent the decline of -57.99% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Shakti Press Ltd for the Jun '26 is ₹ 0.87 crore as compare to the Mar '26 ebitda of ₹ 1.51 crore. This represent the decline of -42.38% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Shakti Press Ltd changed from ₹ 0.04 crore to ₹ 0.43 crore over 9 quarters. This represents a CAGR of 187.35% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Shakti Press Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Shakti Press Ltd

Shakti Press Limited, founded in 1993 in Nagpur, is a premier provider of total solutions for high quality packaging and hi-tech printing.
The Company mainly operates into printing and packaging industry in India.
It offers printing material, such as paper sticker, paper tags, danglers, brochures, duplex cartons, and labels; multi colored corrugated boxes; and stationery.
The company exports its products to Gulf countries. The Company was incorporated to set up, purchase or otherwise acquire a printing machines & to carry on the business of printers, publishers, lithographers, offset printers, stereo types, electro-types, photographic printers, engravers, dies sinkers, numerical printers, box makers, paper bag and account book makers, cardboard package and container manufacturers, type founders, manufacturers of and dealers in playing, visiting, railway, festivals complementary and fancy cards in 2018-19.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Shakti Press Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Shakti Press Ltd is 23 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of November 1, 2026, the Shakti Press Ltd stock price is INR ₹8.28. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Shakti Press Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.